IL104257A - History of benzenethanamine converted by the heterocycle, process and intermediate composition for their preparation and pharmaceutical preparations containing them - Google Patents

History of benzenethanamine converted by the heterocycle, process and intermediate composition for their preparation and pharmaceutical preparations containing them

Info

Publication number
IL104257A
IL104257A IL10425792A IL10425792A IL104257A IL 104257 A IL104257 A IL 104257A IL 10425792 A IL10425792 A IL 10425792A IL 10425792 A IL10425792 A IL 10425792A IL 104257 A IL104257 A IL 104257A
Authority
IL
Israel
Prior art keywords
formula
hydrogen
nitro
halo
cyano
Prior art date
Application number
IL10425792A
Other languages
English (en)
Hebrew (he)
Other versions
IL104257A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL104257A0 publication Critical patent/IL104257A0/xx
Publication of IL104257A publication Critical patent/IL104257A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C07D333/44—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL10425792A 1991-12-30 1992-12-29 History of benzenethanamine converted by the heterocycle, process and intermediate composition for their preparation and pharmaceutical preparations containing them IL104257A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91203431 1991-12-30

Publications (2)

Publication Number Publication Date
IL104257A0 IL104257A0 (en) 1993-05-13
IL104257A true IL104257A (en) 1996-12-05

Family

ID=8208119

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10425792A IL104257A (en) 1991-12-30 1992-12-29 History of benzenethanamine converted by the heterocycle, process and intermediate composition for their preparation and pharmaceutical preparations containing them

Country Status (16)

Country Link
US (5) US5480997A (hu)
EP (1) EP0620811A1 (hu)
JP (1) JPH07502523A (hu)
CN (1) CN1034074C (hu)
AP (1) AP392A (hu)
AU (1) AU658260B2 (hu)
CA (1) CA2125675A1 (hu)
FI (1) FI943119A (hu)
HU (1) HUT70515A (hu)
IL (1) IL104257A (hu)
MX (1) MX9207619A (hu)
NO (1) NO942480L (hu)
PH (1) PH30258A (hu)
TW (1) TW221688B (hu)
WO (1) WO1993013069A1 (hu)
ZA (1) ZA9210078B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587387A (en) * 1991-12-30 1996-12-24 Janssen Pharmaceutica N.V. Heterocycle-substituted benzenemethanamine derivatives
US5767310A (en) * 1993-03-19 1998-06-16 Merck & Co., Inc. Phenoxyphenylacetic acid derivatives
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274190A (en) * 1966-09-20 Hydroxyphenethyl-amino-s-triazine
ES368093A1 (es) * 1968-07-16 1971-07-16 Degussa Procedimiento para la preparacion de bencilaminas n-hetero-ciclicamente sustituidas.
US4246429A (en) * 1978-06-23 1981-01-20 Janssen Pharmaceutica, N.V. Novel α-amino-phenylacetic acid derivatives
WO1991009840A1 (en) * 1989-12-22 1991-07-11 Schering Corporation Mercaptocycloacyl aminoacid endopeptidase inhibitors
ES2093090T3 (es) * 1989-12-28 1996-12-16 Upjohn Co Compuestos sustituidos diaromaticos anti-sida.

Also Published As

Publication number Publication date
US5604230A (en) 1997-02-18
US5480997A (en) 1996-01-02
NO942480D0 (no) 1994-06-30
US5550135A (en) 1996-08-27
AP9200468A0 (en) 1993-01-31
CA2125675A1 (en) 1993-07-08
WO1993013069A1 (en) 1993-07-08
CN1073942A (zh) 1993-07-07
PH30258A (en) 1997-02-05
HU9401380D0 (en) 1994-08-29
AP392A (en) 1995-08-03
FI943119A0 (fi) 1994-06-29
EP0620811A1 (en) 1994-10-26
JPH07502523A (ja) 1995-03-16
ZA9210078B (en) 1994-06-29
IL104257A0 (en) 1993-05-13
FI943119A (fi) 1994-06-29
AU3258093A (en) 1993-07-28
CN1034074C (zh) 1997-02-19
TW221688B (hu) 1994-03-11
AU658260B2 (en) 1995-04-06
HUT70515A (en) 1995-10-30
US5541215A (en) 1996-07-30
NO942480L (no) 1994-06-30
US5552430A (en) 1996-09-03
MX9207619A (es) 1993-06-01

Similar Documents

Publication Publication Date Title
US4226878A (en) Imidazole derivative
US5834463A (en) Condensed heterocyclic compounds, their production and use
EP0610372B1 (en) 1,3-dihydro-2h-imidazo(4,5-b)quinolin-2-one derivatives as phosphodiesterase inhibitors
EP0538301B1 (en) Hiv-inhibiting benzeneacetamide derivatives
CA2100626A1 (en) 4-aminoquinazoline derivatives
JPH11246411A (ja) コルチコトロピン放出因子アンタゴニスト製造用中間体
JPH07509726A (ja) Ｃｒｆアンタゴニストとしてのピロロピリミジン
WO1989003818A1 (en) Novel fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
JP2006519818A (ja) ロフルミラストの新規の製造方法
EP1928833B1 (en) Novel quinoline compounds capable of binding at the cb2 receptor
CA2067663A1 (en) Pyrazine derivatives
EP0620809B1 (en) $g(a)-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES
US5552430A (en) Heterocycle-substituted benzenemethanamine derivatives
EP0344577A2 (en) Butenoic or propenoic acid derivatives
SE436359B (sv) Analogiforfarande for framstellning av 4-substituerade imidazo/1,2-a/kinoxaliner
IE63108B1 (en) Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones
US5587387A (en) Heterocycle-substituted benzenemethanamine derivatives
JPH0232078A (ja) ４―アミノ―３―カルボキシ―ナフチリジン誘導体、その製法および医薬組成物
JPH09501690A (ja) 抗菌活性を有するキノリニル−（１ｈ−１，２，４−トリアゾール−１−イル）アルカノール誘導体
CA1260933A (en) Bicyclic lactams, processes for their preparation and their use, and formulations containing these compounds
JPS6293278A (ja) 新規なイミダゾ−ル誘導体
JPS604182A (ja) ピリミドン誘導体及びその製法
JPS6317865A (ja) イミダゾ−ル誘導体およびその製造法

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void
RH1 Patent not in force